Despite its looming lawsuit with Anthem, the pharmacy benefits manager boosted its expectations for customer renewals.
Some big names in the insurance industry are waving the white flag on Obamacare.
Anthem's revenue and profit came in ahead of projections, but investors' attention is squarely focused on a new lawsuit with the DOJ.
Looking for bargains in the sector best positioned to ride aging demographic trends? These five are screaming buys.
Here's what investors will be looking for in the pharmacy benefits manager's upcoming earnings release and conference call.
The American population is getting older, which is a big reason our contributors are bullish on these three stocks.
The main thing: When the profits are this good, the big picture doesn't matter.
CEO George Paz says Anthem's demands for $3 billion in annual savings are "ludicrous."
The health insurer posted better revenue and earnings results than most had expected.
Can the pharmacy benefit manager make amends with its largest customer? Or is Express Scripts about to lose a huge portion of its revenue? Investors will be searching for answers to these questions in the days ahead.